As the BNP produced in decompensated heart failure is not enough to antagonize the activated rennin‐angiotensin‐aldosterone system (RAAS) and sympathetic nervous system (SNS), so exogenous recombinant human BNP is widely used to treat decompensated heart failure.29 The gene discussed is NPPB; the disease is heart failure.